Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.
Published

Faces of HPPD: Hallucinogen Persisting Perception Disorder Patient Survey Results and a Descriptive Analysis of Patient Demographics, Medical Background, Drug Use History, Symptoms, and Treatments

Objective: The purpose of the present study was to obtain patient information across a wide geography about medical history, drug use, symptoms, and treatments of individuals diagnosed with hallucinogen persisting perception disorder (HPPD). Methods: The study was an internet survey that yielded 26 HPPD patients from North America (81%), Europe (12%), and South America (almost 8%), predominantly male (73%), white (92%), with a median age of 24.5 (range, 18 to 63) years, who have been living with HPPD from a period of

Open source BibTeX RIS

Bibliographic context

Journal
Addictive Disorders & Their Treatment
Date
2019-06-09
Source
OpenAlex
DOI
10.1097/adt.0000000000000178
PubMed
Unavailable

Authors

Doreen M. Lewis
Watch author

Topics and keywords

psilocybin AnxietyReceptor PharmacologyEmotional ProcessingObservational StudyToxicity Observational Study PsilocybinHallucinogenLysergic acid diethylamidePsychiatryAnxietyPsychiatric historySuicidal ideationMedicineDepersonalizationPsychologyClinical psychologyPoison controlSuicide preventionInternal medicineBurnoutReceptorSerotoninEmotional exhaustionEnvironmental healthPsychedelics and Drug Studies

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Faces of HPPD: Hallucinogen Persisting Perception Disorder Patient Survey Results and a Descriptive Analysis of Patient Demographics, Medical Background, Drug Use History, Symptoms, and Treatments2019-06-09

Related papers

Mechanistic insights toward dissociating therapeutic from psychedelic effects: bridging the gap between psychedelic research and mental health careTranslational Psychiatry · 2026-06-23Beyond Psychedelic Microdosing: Therapeutic Potential, Neuropharmacology, and Safety Considerations in Low-Dose Psychoactive UseJournal of Advances in Developmental Research · 2026-06-17A cross-national comparison of nonmedical and medical use of psychedelic drugs in the international cannabis policy studyInternational Journal of Drug Policy · 2026-06-04Therapeutic potential of psilocybin in the pharmacological treatment of obsessive-compulsive disorder: a scoping review protocol.Open Science Framework · 2026-07-08Acute Hallucinogen Intoxication Following Ingestion of a Commercially Available Mushroom Extract Product: A Case ReportCureus · 2026-06-12Classic Psychedelics for Chronic Pain: A Critical Review of the Literature and Practical Advice for CliniciansDrugs · 2026-06-03Psilocybe Poisoning: Pathophysiology, Classification and Treatment. A Clinical Case ReviewMexican Journal of Medical Research ICSA · 2026-07-04Policy Considerations for Psychedelics in Research and Medicine - What’s Next on the Schedule?Journal of Science Policy & Governance · 2026-07-01